Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal CancerLiang Zhang, Xiaoen Wang, Andrea J Bullock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell CarcinomaThomas Denize, Yue Hou, Jean-Christophe Pignon, et al.
Science Translational Medicine|January 21, 2021
ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinomaPrateek Khanna, Hong Jie Soh, Chun-Hau Chen, et al.
Cancer Cell|November 16, 2010
FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesisBoyi Gan, Carol Lim, Gerald Chu, et al.
The Lancet. Oncology|October 2, 2025
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer ConsortiumJames P Blackmur, J C Koen van der Mijn, Anne Y Warren, et al.
Cancer Immunology Research|May 28, 2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell CarcinomaMarcella Callea, Laurence Albiges, Mamta Gupta, et al.
Cancer Research|May 28, 2009
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidneyRameen Beroukhim, Jean-Philippe Brunet, Arianna Di Napoli, et al.
Oncotarget|December 22, 2017
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expressionAly-Khan A Lalani, Kathryn P Gray, Laurence Albiges, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
Pageof 25